Toll-Like Receptor 2 Pathway Drives Streptococcal Cell Wall-Induced Joint Inflammation: Critical Role of Myeloid Differentiation Factor 88

Journal of Immunology

Volumn 171, Issue 11, 2003, Pages 6145-6153

  Joosten, Leo A B ^a   Koenders, Marije I ^a   Smeets, Ruben L ^a   Heuvelmans Jacobs, Marleen ^a   Helsen, Monique M A ^a   Takeda, Kiyoshi ^b   Akira, Shizuo ^b   Lubberts, Erik ^a   Van De Loo, Fons A J ^a   Van Den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PROTEOGLYCAN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL CELL WALL; CARTILAGE CELL; CARTILAGE MATRIX; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTOLOGY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SYNOVIUM;

EID: 10744223444     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.11.6145     Document Type: Article

References (57)

1. O'Neill, L. A., and C. A. Dinarello. 2000. The IL-I receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21:206.
2. Aderem, A., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782.
3. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135.
4. Barton, G. M., and R. Medzhitov. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:380.
5. Janeway, C. A., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
6. Bowie, A., and L. A. J. O'Neill. 2000. The interleukin-1/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukocyte Biol. 67:508.
7. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603.
8. Vinuese, C. G., and C. C. Goodnow. 2002. DNA drives autoimmunity. Nature 416:595.
9. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095.
10. Van den Berg, W. B. 2001. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res. 3:18.
11. Dayer, J. M., and B. Bresnihan. 2002. Targeting interteukin-1 in the treatment of rheumatoid arthritis. Arthritis Rheum. 46:574.
12. Dinarello, C. A. 2000. Interleukin-18, a proinflammatory cytokine. Eur. Cytokine Network, 11:483.
13. Dayer, J. M. 1999. Interleukin-18, rheumatoid arthritis and tissue destruction. J. Clin. Invest. 104:1337.
14. Gracie, A. J., R. J. Forsey, W. L. Chan, A. Gilmour, B. P. Leung, M. R. Greer. K. Kennedy, R. Carter, X. Q. Wei, D. Xu. et al. 1999. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 104:1393.
15. Olee, T., S. Hashimoto, J. Quach, and M. Lotz. 1999. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J. Immunol. 162:1096.
16. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88.
17. Okamura, H., H. Tsutsui, S. Kashiwamura, T. Yoshimoto, and K. Nakanish. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:281.
18. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK activity and Th1 responses in IL-18 deficient mice. Immunity 8:383.
19. Akira, S. 2000. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12:59.
20. Yamamura, M., M. Kawashima, M. Taniai, H. Yamauchi, T. Tanimoto, M. Murimoto, Y. Morita, Y. Ohmoto, and H. Makino. 2001. Interferon-γ -inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum. 44:275.
21. Tanaka, M., M. Harigai, Y. Kawaguchi, S. Ohta, T. Sugiura, K. Takagi, S. Ohsako-Higami, C. Fukasawa, M. Hara, and N. Kamatani. 2001. Mature form of interleukin-18 is expressed in rheumatoid arthritis synovial tissue and contributes to interferon-γ production by synovial T cells. J. Rheumatol. 28:1779.
22. Plater-Zyberk, C., L. A. B. Joosten, M. M. A. Helsen, P. Sattonnet-Roche, C. Siegfried, S. Alouani, F. A. J. van de Loo, P. Graber, S. Aloni S. R. Cirillo, et al. 2001. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J. Clin. Invest. 108:1825.
23. Smeets, R. L., F. A. J. Van de Loo, O. J. Arntz, M. B. Bennink, L. A. B. Joosten, and W. B. Van den Berg. 2003. Local inhibtion of IL-18 through adenoviral overexpression of IL-18BP ameliorates collagen-induced arthritis in mice. Gene Ther. 10:632.
24. Joosten, L. A. B., T. R. D. Radstake, E. Lubberts, L. A. M. van den Bersselaar, P. L. C. M. van Riel, P. L. E. M. van Lent, P. Barrera, and W. B. van den Berg. 2003. Association of interleukin-18 expression with enhanced levels of both interleukin-1β and tumor necrosis factor a in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 48:339.
25. Wesche, H., W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837.
26. Burns, K., F. Martinon, C. Esslinger, H. Pahl, P. Schneider, J. L. Bodmer, F. Di Marco, L. French, and J. Tschopp. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273:12203.
27. Li, S., A. Strelow, E. J. Fontana, and H. Wesche. 2002. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 99:5567.
28. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143.
29. Dupraz, P., S. Cottet, F. Hamburger, W. Dolci, E. Felley-Bosco, and B. Thorens. 2000. Dominant negative MyD88 proteins inhibit interleukin-1β /interferon-γ-mediated induction of nuclear factor κB-dependent nitrite production and apoptosis in β cells. J. Biol. Chem. 275:37672.
30. Takeuchi, O., K. Hoshino, and S. Akira. 2000. TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392.
31. Horai, R., M. Asano, K. Sudo, H. Kanuka, M. Suzuki, M. Nishihara, M. Takahashi, and Y. Iwakura. 1998. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187:1463.
32. Van den Broek, M. F., W. B. van den Berg, L. B. A. van de Putte, and A. J. Severijnen. 1988. Streptococcal cell wall induced arthritis and flare-up reactions in mice induced by homologous and heterologous cell walls. Am. J. Pathol. 133:139.
33. 99mTc-pertechnetate uptake. Agents Actions 14:723.
34. Joosten, L. A. B., F. A. J. van de Loo, E. Lubberts, M. M. A. Helsen, M. G. Netea, J. W. M. van der Meer, C. A. Dinarello, and W. B. van den Berg. 2000. An IFN-γ-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J. Immunol. 165:6553.
35. De Jager, W., H. Te Velthuis, B. J. Prakken, W. Kuis, and G. T Rijkers. 2003. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10:133.
36. Van Meurs, J. B. J., P. L. E. M. van Lent, L. A. B. Joosten, P. M. van de Kraan, and W. B. van den Berg. 1997. Quantification of mRNA levels in joint capsule and articular cartilage on the murine knee joint by RT-PCR. Rheum. Int. 16:197.
37. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
38. Kuiper, S., L. A. B. Joosten, A. M. Bendele, C. K. Edwards III, O. J. Arntz, M. M. A. Helsen, F. A. J. Van de Loo, and W. B. van den Berg. 1998. Different roles of tumour necrosis factor α and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 10:690.
39. Van den Berg, W. B. 2000. Arguments for interleukin 1 as a target in chronic arthritis. Ann. Rheum. Dis. 59(Suppl 1):1.
40. Van de Loo, F. A. J., L. A. B. Joosten, P. L. E. M. van Lent, O. J. Arntz, and W. B. van den Berg. 1995. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction: effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38:164.
41. Kyburz, D., J. Rethage, R. Seibl, R. Lauener, R. E. Gay, D. A. Carson, and S. Gay. 2003. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by Toll-like receptor signaling. Arthritis Rheum. 48:642.
42. Kawashima, M., and P. Miossec. 2003. Heterogeneity of response of rheumatoid synovium cell subsets to interleukin-18 in relation to differential interleukin-18 receptor expression. Arthritis Rheum. 48:631.
43. Miyazaki, S., A. Matsukawa, S. Ohkawara, K. Takagi, and M. Yoshinaga. 2000. Neutrophil infiltration as a crucial step for monocyte chemoattractant protein (MCP)-1 to attract monocytes in lipopolysaccharide-induced arthritis in rabbits. Inflamm. Res. 49:673.
44. Esser, R. E., S. K. Anderle, C. Chetty, S. A. Stimpson, W. J. Cromartie, and J. H. Schwab. 1986. Comparison of inflammatory reactions induced by intraarticular injection of bacterial cell wall polymers. Am. J. Pathol. 122:323.
45. Deng, G. M., I. M. Nilsson, M. Verdrengh, L. V. Collins, and A. Tarkowski. 1999. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5:702.
46. Deng, G. M., and A. Tarkowski. 2000. The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum. 43:356.
47. Dziarski. R., and D. Gupta. 2000. Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes. J. Endotoxin Res. 6:401.
48. Asea, A., M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, and S. K. Calderwood. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J. Biol Chem. 277:15028.
49. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos. and J. C. Simon. 2002. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp Med. 195:99.
50. Van de Loo, F. A., O. J. Arntz, F. H. van Enckevort, P. L. van Lent, and W. B. van den Berg. 1998. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation. Arthritis Rheum. 41:634.
51. Choe, J. Y., B. Crain, S. R. Wu, and M. Corr. 2003. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by Toll-like receptor 4 signaling. J. Exp. Med. 197:537.
52. Van Beuningen, H. M., R. Stoop, P. Buma, N. Takahashi, P. M. van der Kraan, and W. B. van den Berg. 2002. Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage. Osteoarthritis Cartilage 10:977.
53. Barnes, D. A., J. Tse, M. Kaufhold, M. Owen, J. Hesselgesser, R. Strieter, R. Horuk, and H. D. Perez. 1998. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J. Clin. Invest. 101:2910.
54. Tsuboi, N., T. Yoshikai, S. Matsuo, T. Kikuchi, K. Iwami, Y. Nagai, O. Takeuchi, S. Akira, and T. Matsuguchi. 2002. Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J. Immunol. 169:2026.
55. Van den Berg, W. B. 2001. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin. Arthritis. Rheum. 30:16.
56. Janssens, S., and R. Beyaert. 2002. A universal role for MyD88 in TLR/IL-IR-mediated signaling. Trends Biochem. Sci. 27:474.
57. Burns, K., S. Janssens, B. Brissoni, N. Olivos, R. Beyaert, and J. Tschopp. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197:263.